Skip to content

Mega Pharma

Active Private limited companyfounded 2011active for 15 yearsLeopold II laan 75, 1080 Molenbeek-Saint-JeanKBO/BCE: BE 0840.972.479

Annual accounts 2025

micro format, filed on 29-07-2026, 2 days before the deadline
€130,361
▼ 20.8%
-€20,935
▼ €58,324
-€30,878
▼ €38,752
€46,323
▲ 16.5%
35.6%
▼ 3.2 percentage points
1.22
▲ 0.04

The turnover shown is an estimate from the gross margin.

Turnover ≈ €390,000. Estimated: probably between €280,000 and €740,000.

Balance sheet

balance sheet total €370,696 on 31-12-2025
What the company ownsHow it is paid for

in euro

in euro

Position in the sector

35.6%

Higher than 52% of 25,237 companies in 2025.

1.22

Higher than 41% of 24,245 companies in 2025.

-8.3%

Higher than 19% of 24,434 companies in 2025.

Mega Pharma Middle half of the sector 80% of the sector Micro accounts in retail trade (NACE 47)

Net result: bottom quarter · Equity: top quarter · Balance sheet total: top quarter · Working capital: middle half

Staff

€34,307

Staff costs divided by the average number of full-time equivalents.

-1 person

people who joined people who left

In 2025, 1 person joined and 2 left.

Filed annual accounts

as filed with the National Bank, click a year to choose it
Line Trend20252024202320222021202020192018201720162015201420132012
Balance sheet: assets
20/58 370,696419,628525,516462,366511,229524,069541,640552,61015,70714,90913,83813,22112,52112,730
21/28 112,953163,508214,063191,850231,407270,964304,920342,920------
21 66,00099,000132,000165,000198,000231,000264,000297,000------
22/27 46,03363,58881,14325,93032,48739,04440,00045,000------
23 10,62415,87221,11925,93032,48739,04440,00045,000------
24 35,40947,71660,023-----------
28 920920920920920920920920------
29/58 257,743256,120311,454270,517279,822253,104236,721209,69015,70714,90913,83813,22112,52112,730
3 38,67664,98164,97562,44854,65068,06860,98259,780------
30/36 38,67664,98164,97562,44854,65068,06860,98259,780------
40/41 125,774138,011178,646187,637183,979161,38191,81856,22115,69314,88113,77613,12512,41712,622
40 56,77457,34348,25548,72451,46143,41559,05251,221------
41 69,00080,668130,391138,913132,518117,96632,7665,00015,69314,88113,77613,12512,41712,622
54/58 91,68953,12867,63620,23239,75022,73982,11593,42114286296105108
490/1 1,60201971991,4429161,806268------
Balance sheet: equity and liabilities
10/49 370,696419,628525,516462,366511,229524,069541,640552,61015,70714,90913,83813,22112,52112,730
10/15 131,985162,863154,989183,451139,019142,897104,46950,99112,23114,58313,71013,20712,52111,980
10/11 12,40012,40012,40012,40012,40012,40012,40012,40012,40012,40012,40012,40012,40012,400
100 ------18,60018,60018,60018,60018,60018,60018,60018,600
101 ------6,2006,2006,2006,2006,2006,2006,2006,200
13 119,585150,463142,58938,59138,59138,59138,59138,591344344300200100-
130/1 --0591591591--------
130 ------1,8601,860344344300200100-
1311 --0591591591--------
133 119,585150,463142,58938,00038,00038,00036,73136,731------
14 -00132,46088,02891,90653,478--5131,8391,01060721-420
17/49 238,710256,764370,527278,915372,210381,172437,172501,6193,47732612814-750
17 26,51939,54263,13187,014141,822205,539268,182329,770------
170/4 26,51939,54263,13187,014141,822205,539268,182329,770------
42/48 211,420216,344306,524191,491230,388175,633168,516171,1573,47732612814-750
42 30,71729,12587,90674,80863,71764,58666,67365,550------
43 46,00056,12856,00033,00068,00015,00015,00020,000------
430/8 46,00056,12856,00033,00038,00015,00015,00020,000------
439 ----30,000---------
44 109,230103,89798,66562,39672,17277,10071,99168,0353,477----750
440/4 109,230103,89798,66562,39672,17277,10071,99168,0353,477----750
45 25,47327,19425,95421,28726,49918,94814,8513,607-32612814--
450/3 8,90514,53712,58013,40418,17612,87110,6943,607-32612814--
454/9 16,56712,65713,3747,8838,3246,0764,157-------
47/48 -038,000---013,964------
492/3 771878872410-0474692------
Income statement
9900 130,361164,640126,325159,696113,553116,525133,313103,536-51-156-263-154-310-1,146
62 99,49073,20164,90947,17972,60424,88415,508-------
630 50,55550,55540,56139,55739,55738,62838,00038,000------
640/8 1,2523,4961,0951,1884,0272,3051,9301,8983,477--3--
9901 -20,93537,38919,76071,773-2,63550,70877,87563,638-3,528-156-263-156-310-1,146
75/76B 4,0016,0437,1368,5987,4176,834653741,2861,260914864858734
75 4,0016,0437,1368,5987,4176,834653741,2861,260914864858734
65/66B 13,94427,58711,76822,8318,1629,12410,1869,952343434978
65 13,94427,58711,76822,8318,1629,12410,1869,952343434978
9903 -30,87815,84515,12957,539-3,37948,41968,34253,760-2,2761,071618699541-420
67/77 07,9705,59113,1074999,99014,86415,00076198114140-
9904 -30,8787,8749,53844,432-3,87838,42853,47838,760-2,352873503685541-420
9905 -30,8787,8749,53844,432-3,87838,42853,47838,760-2,352873503685541-420
Appropriation of the result
9906 -30,8787,874141,998132,46088,02891,90653,47838,247-5131,8831,110707121-420
14P -0132,46088,02891,906---------
791/2 30,878038,000-----------
691/2 07,874141,998---038,247-44100100100-
6920 ------01,516-44100100100-
6921 07,874141,998---036,731------
694/7 -038,000-----------
694 -038,000-----------
Social balance sheet
9087 2.92.310.81.20.50.5-------
Hours worked1013 3,2132,0281,8141,4272,053783798-------
Document PDFPDFPDFPDFPDFPDFPDFPDFPDFPDFPDFPDFPDFPDF

The notes to these accounts have 15 items, including the statement of assets and debts, the cost breakdown and rights and commitments. You find them in the accounts filed with the NBB.

Source: Annual accounts 2025 at the NBB, filed on 29-07-2026.

Download as CSV

Filings

each dot is a set of accounts, on the day it reached the National Bank
Financial year Type Filed Reference Document
31-12-2025 micro format 29-07-2026 2026-00360143 PDF
31-12-2024 micro format 17-06-2025 2025-00145875 PDF
31-12-2023 full format 06-06-2024 2024-00119715 PDF
31-12-2022 full format 10-07-2023 2023-00243050 PDF
31-12-2021 full format 15-07-2022 2022-20190664 PDF
31-12-2020 micro format 12-07-2021 2021-34900037 PDF
31-12-2019 micro format 28-05-2020 2020-13500249 PDF
31-12-2018 micro format 24-06-2019 2019-21400318 PDF
31-12-2017 micro format 21-06-2018 2018-21300221 PDF
31-12-2016 micro format 31-07-2017 2017-39900178 PDF
31-12-2015 full format 29-08-2016 2016-54000143 PDF
31-12-2014 full format 24-08-2015 2015-50900454 PDF
31-12-2013 full format 17-07-2014 2014-33400127 PDF
31-12-2012 full format 29-07-2013 2013-38400507 PDF

Key figures and ratios

per financial year, computed from the annual accounts
Line Trend20252024202320222021202020192018201720162015201420132012
29,62087,94460,321111,33036,92289,336115,875101,638------
19,67758,42950,09983,98935,67977,05691,47876,761------
0062,774004,6720380,920------
38,561-14,50847,403-19,51817,011-59,375-11,30693,407-14-34-34-9-3-
46,32339,7764,92979,02549,43477,47168,20538,53312,23114,58313,71013,207-11,980
35.6%38.8%29.5%39.7%27.2%27.3%19.3%9.2%77.9%97.8%99.1%99.9%100.0%94.1%
1.221.181.021.411.211.441.401.234.5245.75---16.97
1.040.880.801.090.981.051.040.884.5245.75---16.97
1.811.582.391.522.682.674.189.840.280.020.010.00-0.06
-23.4%4.8%6.2%24.2%-2.8%26.9%51.2%76.0%-19.2%6.0%3.7%5.2%4.3%-3.5%
-8.3%1.9%1.8%9.6%-0.8%7.3%9.9%7.0%-15.0%5.9%3.6%5.2%4.3%-3.3%
2.123.195.134.884.52---------

EBIT margin: not included in this filing.

A Belgian filing has no cash-flow statement. Cash flow is therefore an approximation, derived from the income statement. Investment is the acquisitions in the notes and, without them, the balance-sheet move.

Social balance sheet

Item31-12-202531-12-202431-12-202331-12-202231-12-2021
Employees at the balance-sheet date23221
full-time00000
part-time23221
in full-time equivalents1.31.6110.5
1.81.210.81.2
On a permanent contract22221
Joined11-31
Left20-21

Source: social balance sheet in the 2021 to 2025 annual accounts

Securities and guarantees

on own assets and for others
Item20252024202320222021
Debts secured on the company's own assets--€141,037€141,822€205,539
---€250,000€250,000
€490,000€490,000€490,000€490,000€490,000

Source: notes to the 2021 to 2025 annual accounts (statement of debts and off-balance-sheet rights and commitments)

Investments

fixed assets acquired
Item20252024202320222021
Tangible fixed assets--€62,774--
Financial fixed assets€0----
€50,555€50,555€40,561€39,557€39,557

Source: notes to the 2021 to 2025 annual accounts (statement of fixed assets)

Insights on Mega Pharma

The operating result for 2025 is a loss of €20,935, after a profit of €37,389 in 2024. It is the lowest result since 2012.

Debt's share of the balance-sheet total rises from 61.2% to 64.4%. Equity and debt are lower.

Next steps